2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
Yield10 Bioscience Announces Two New Hires as Camelina Business Plan Advances
—Dr. Munyikwa Appointed as Director of Regulatory Affairs— —Dr. Renegar Appointed as Director, Business Analytics and Operations— WOBURN, Mass., June...
Evoke Pharma, EVERSANA and The International Foundation for Gastrointestinal Disorders Announce Membership into IFFGD’s Industry Council
Extends commitment toward supporting patients experiencing Diabetic Gastroparesis through focused collaborations and Sponsorship of the 30th Anniversary Digestive Health Virtual...
Odyssey Group International Reports Achieving Drug Safety Standards for Clinical Trials of its Drug for Treating Concussion
IRVINE, CA, June 29, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and...
Celularity Announces Expansion of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Phase 1 Trial in Patients with Acute Myeloid Leukemia
No dose limiting toxicity to date with outpatient administration of three doses (Days 0, 7 and 14) at total dose...
Aleafia Health Announces Results of Annual General Meeting
TORONTO, June 29, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a...
(“OKYO” or the “Company”) – OKYO Pharma Retains Ora Inc. to Perform Regulatory Development of OK-101 for Dry Eye Indications
LONDON and BOSTON, June 29, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused...
TRACON Pharmaceuticals Announces Orphan Drug Designation for Envafolimab in Soft Tissue Sarcoma
Application Included Clinical Trial Data from Soft Tissue Sarcoma Patients Treated with Envafolimab in Phase 1 Trials SAN DIEGO, June...
Akoya to Partner with Nikon, CrestOptics and Andor to Enable New Spatial Biology Applications through the Imaging Innovators (I2) Network
Company plans to work with multiple microscope partners to broaden access to the CODEX® solution for single-cell, multiplexed imaging Breast...
Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors
CORAL GABLES, Fla., June 29, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company...
Development of BioVie’s NE3107 Asset Featured by the American Diabetes Association
NE3107 Featured in the ADA’s Thought Leadership Film Series at Annual Scientific SessionSANTA MONICA, Calif., June 29, 2021 (GLOBE NEWSWIRE)...
HiberCell Appoints Mark J. Mulvihill, Ph.D., Chief Scientific Officer
Industry veteran promoted to oversee discovery of HiberCell’s scientific pipelineNEW YORK, June 29, 2021 (GLOBE NEWSWIRE) -- HiberCell, a biotechnology...
VYNE Therapeutics to Participate in the 2nd Annual JAK Inhibitors Drug Development Digital Event
BRIDGEWATER, N.J., June 29, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that...
Paratek Pharmaceuticals Announces First BARDA Project BioShield Procurement of NUZYRA® (omadacycline) Valued at ~$38 Million
-- First BARDA Procurement has been Delivered and Revenue will be Recognized in Second Quarter 2021BOSTON, June 29, 2021 (GLOBE...
Allied Corp Signs Psilocybin Manufacturing Agreement To Produce Psilonex™ RX For What We Believe To Be The Largest Known Psilocybin Patient Cohort In The World
KELOWNA, British Columbia., June 29, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
H-CYTE Announces Publication of Positive Real-World Data Relating to the Use of Innovative Treatment (PRP-PBMC) Aimed at Helping Improve Overall Lung Health
Statistically Significant Improvement in Pulmonary Function at Both 3 Months and 12 Months Post TreatmentTAMPA, Fla., June 29, 2021 (GLOBE...
Propella Announces First Patient Dosed in Phase 1/2a Trial of PRL-02 for Treatment of Metastatic Prostate Cancer
Next-Generation Androgen Biosynthesis Inhibitor with Long Duration of Activity and Superior Therapeutic IndexPITTSBORO, N.C., June 29, 2021 (GLOBE NEWSWIRE) --...
Reneo Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
SAN DIEGO, June 29, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on...
Cend Therapeutics’ CEND-1 Granted Fast Track Designation for Pancreatic Cancer
SAN DIEGO, June 29, 2021 (GLOBE NEWSWIRE) -- The US Food and Drug Administration (FDA) has granted Fast Track Development...
Elicio Therapeutics Announces Initiation of Its Phase 1/2 Dose-Escalation Study of ELI-002 (AMPLIFY-201) in KRAS-Driven Cancers
Study will evaluate the safety and preliminary efficacy of ELI-002, an investigational lymph node-targeted therapeutic vaccine in patients with KRAS-driven...
Cullinan Oncology Receives FDA Clearance of Investigational New Drug (IND) Application for CLN-619, a Novel MICA/B-targeted Antibody for the Treatment of Solid Tumors
CLN-619 will be the first MICA/B-targeted antibody to enter human clinical trialsCullinan will initiate a FIH trial in 3Q21, including...